HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Concerted suppression of STAT3 and GSK3β is involved in growth inhibition of non-small cell lung cancer by Xanthatin.

Abstract
Xanthatin, a sesquiterpene lactone purified from Xanthium strumarium L., possesses prominent anticancer activity. We found that disruption of GSK3β activity was essential for xanthatin to exert its anticancer properties in non-small cell lung cancer (NSCLC), concurrent with preferable suppression of constitutive activation of STAT3. Interestingly, inactivation of the two signals are two mutually exclusive events in xanthatin-induced cell death. Moreover, we surprisingly found that exposure of xanthatin failed to trigger the presumable side effect of canonical Wnt/β-Catenin followed by GSK3β inactivation. We further observed that the downregulation of STAT3 was required for xanthatin to fine-tune the risk. Thus, the discovery of xanthatin, which has ability to simultaneously orchestrate two independent signaling cascades, may have important implications for screening promising drugs in cancer therapies.
AuthorsLi Tao, Fangtian Fan, Yuping Liu, Weidong Li, Lei Zhang, Junshan Ruan, Cunsi Shen, Xiaobo Sheng, Zhijie Zhu, Aiyun Wang, Wenxing Chen, Shile Huang, Yin Lu
JournalPloS one (PLoS One) Vol. 8 Issue 11 Pg. e81945 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID24312384 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Furans
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • beta Catenin
  • xanthatin
  • GSK3B protein, human
  • Glycogen Synthase Kinase 3 beta
  • Glycogen Synthase Kinase 3
Topics
  • Antineoplastic Agents (pharmacology, therapeutic use)
  • Apoptosis
  • Carcinoma, Non-Small-Cell Lung (enzymology, metabolism, pathology)
  • Cell Line, Tumor
  • Cell Proliferation
  • Furans (pharmacology, therapeutic use)
  • Glycogen Synthase Kinase 3 (antagonists & inhibitors, metabolism)
  • Glycogen Synthase Kinase 3 beta
  • Humans
  • Lung Neoplasms (enzymology, metabolism, pathology)
  • RNA Processing, Post-Transcriptional
  • STAT3 Transcription Factor (antagonists & inhibitors, metabolism)
  • beta Catenin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: